extremely significantP < 0.01
On day 12 after treatments, tumor volume between myristoyl-CM4 (or ciaplatin) treatment and PBS (or CM4) treatment showed extremely significant differences ( P < 0.01) (Figure 6C ).
On day 12 after treatments, tumor volume between myristoyl-CM4 (or ciaplatin) treatment and PBS (or CM4) treatment showed extremely significant differences ( P < 0.01) (Figure 6C ).